Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 60 (2) , 741-747
- https://doi.org/10.1046/j.1523-1755.2001.060002741.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- European Best Practice Guidelines 6–8 Assessing and optimizing iron storesNephrology Dialysis Transplantation, 2000
- Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failureAmerican Journal of Kidney Diseases, 2000
- Increasing the Hematocrit Has a Beneficial Effect on Quality of Life and Is Safe in Selected Hemodialysis PatientsJournal of the American Society of Nephrology, 2000
- Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patientsAmerican Journal of Kidney Diseases, 1995
- Double-Blind, Placebo-Controlled Study of the Therapeutic Use of Recombinant Human Erythropoietin for Anemia Associated With Chronic Renal Failure in Predialysis PatientsAmerican Journal of Kidney Diseases, 1991
- Clinical Pharmacokinetics of Epoetin (Recombinant Human Erythropoietin)Clinical Pharmacokinetics, 1991
- Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietinThe American Journal of Medicine, 1990
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987